From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare

Research output: Contribution to journalArticleAcademicpeer-review

48 Citations (Scopus)
2 Downloads (Pure)

Abstract

Many countries have national guidelines for performing economic evaluations in healthcare.1 These guidelines should ensure the comparability and quality of such evaluations, which should facilitate making well informed policy decisions regarding reimbursement of interventions. Given the developments in both the methodology and policy context of economic evaluation of healthcare interventions, these guidelines require periodical revision. Recently, the Dutch National Health Care Institute issued new guidance for economic evaluations in healthcare [1]. The new guidelines update and replace three separately published previous guidelines: those for pharmacoeconomic evaluation (latest version 2006), outcomes research (latest version 2008) as well as the Dutch costing manual (latest version 2010). In this editorial, we highlight the distinguishing features of the new Dutch guidelines. Moreover, we highlight which developments, in our opinion, are desirable in coming updates, but are still in development or controversial.
Original languageEnglish
Pages (from-to)1071-1074
Number of pages4
JournalPharmacoeconomics (Print)
Volume34
Issue number11
DOIs
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare'. Together they form a unique fingerprint.

Cite this